2,170
Views
18
CrossRef citations to date
0
Altmetric
Reviews

Molecular mechanisms of postbiotics in colorectal cancer prevention and treatment

ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon

References

  • Afrin, S., F. Giampieri, M. Gasparrini, T. Y. Forbes-Hernández, D. Cianciosi, P. Reboredo-Rodriguez, J. Zhang, P. P. Manna, M. Daglia, A. G. Atanasov, et al. 2020. Dietary phytochemicals in colorectal cancer prevention and treatment: A focus on the molecular mechanisms involved. Biotechnology Advances 38:107322. doi: 10.1016/j.biotechadv.2018.11.011.
  • Aguilar-Toalá, J., R. Garcia-Varela, H. Garcia, V. Mata-Haro, A. González-Córdova, B. Vallejo-Cordoba, and A. Hernández-Mendoza. 2018. Postbiotics: An evolving term within the functional foods field. Trends in Food Science & Technology 75:105–14. doi: 10.1016/j.tifs.2018.03.009.
  • Altonsy, M. O., S. C. Andrews, and K. M. Tuohy. 2010. Differential induction of apoptosis in human colonic carcinoma cells (Caco-2) by Atopobium, and commensal, probiotic and enteropathogenic bacteria: Mediation by the mitochondrial pathway. International Journal of Food Microbiology 137 (2-3):190–203. doi: 10.1016/j.ijfoodmicro.2009.11.015.
  • Ambalam, P., J. Dave, B. M. Nair, and B. Vyas. 2011. In vitro mutagen binding and antimutagenic activity of human Lactobacillus rhamnosus 231. Anaerobe 17 (5):217–22. doi: 10.1016/j.anaerobe.2011.07.001.
  • Ambalam, P., M. Raman, R. K. Purama, and M. Doble. 2016. Probiotics, prebiotics and colorectal cancer prevention. Best Practice & Research. Clinical Gastroenterology 30 (1):119–31. doi: 10.1016/j.bpg.2016.02.009.
  • Amedei, A., M. P. Bergman, B. J. Appelmelk, A. Azzurri, M. Benagiano, C. Tamburini, R. van der Zee, J. L. Telford, C. M. J. E. Vandenbroucke-Grauls, M. M. D'Elios, et al. 2003. Molecular mimicry between Helicobacter pylori antigens and H+, K+–adenosine triphosphatase in human gastric autoimmunity. The Journal of Experimental Medicine 198 (8):1147–56. doi: 10.1084/jem.20030530.
  • An, B. C., S. Hong, H. J. Park, B.-K. Kim, J. Y. Ahn, Y. Ryu, J. H. An, and M. J. Chung. 2019. Anti-colorectal cancer effects of probiotic-derived p8 protein. Genes 10 (8):624. doi: 10.3390/genes10080624.
  • Anal, A. K., and H. Singh. 2007. Recent advances in microencapsulation of probiotics for industrial applications and targeted delivery. Trends in Food Science & Technology 18 (5):240–51. doi: 10.1016/j.tifs.2007.01.004.
  • Anese, M., F. Bot, A. Panozzo, G. Mirolo, and G. Lippe. 2015. Effect of ultrasound treatment, oil addition and storage time on lycopene stability and in vitro bioaccessibility of tomato pulp. Food Chemistry 172:685–91. doi: 10.1016/j.foodchem.2014.09.140.
  • Appel-da-Silva, M. C., G. A. Narvaez, L. R. Perez, L. Drehmer, and J. Lewgoy. 2017. Saccharomyces cerevisiae var. Boulardii fungemia following probiotic treatment. Medical Mycology Case Reports 18:15–7. doi: 10.1016/j.mmcr.2017.07.007.
  • Arora, M., A. Baldi, N. Kapila, S. Bhandari, and K. Jeet. 2019. Impact of probiotics and prebiotics on colon cancer: Mechanistic insights and future approaches. Current Cancer Therapy Reviews 15 (1):27–36. doi: 10.2174/1573394714666180724122042.
  • Arthur, J. C., E. Perez-Chanona, M. Mühlbauer, S. Tomkovich, J. M. Uronis, T.-J. Fan, B. J. Campbell, T. Abujamel, B. Dogan, A. B. Rogers, et al. 2012. Intestinal inflammation targets cancer-inducing activity of the microbiota. Science ( Science 338 (6103):120–3. doi: 10.1126/science.1224820.
  • Arun, K., A. Madhavan, T. Reshmitha, S. Thomas, and P. Nisha. 2019. Short chain fatty acids enriched fermentation metabolites of soluble dietary fibre from Musa paradisiaca drives HT29 colon cancer cells to apoptosis. Plos One 14 (5):e0216604. doi: 10.1371/journal.pone.0216604.
  • Awaisheh, S., M. Obeidat, H. Al-Tamimi, A. Assaf, J. EL-Qudah, and R. Rahahleh. 2016. In vitro cytotoxic activity of probiotic bacterial cell extracts against Caco-2 and HRT-18 colorectal cancer cells. Milk Science International-Milchwissenschaft 69 (7):33–7.
  • Bafeta, A., M. Koh, C. Riveros, and P. Ravaud. 2018. Harms reporting in randomized controlled trials of interventions aimed at modifying microbiota: A systematic review. Annals of Internal Medicine 169 (4):240–7. doi: 10.7326/M18-0343.
  • Bahmani, S., N. Azarpira, and E. Moazamian. 2019. Anti-colon cancer activity of Bifidobacterium metabolites on colon cancer cell line SW742. The Turkish Journal of Gastroenterology 30 (9):835–42. doi: 10.5152/tjg.2019.18451.
  • Bartkiene, E., V. Bartkevics, E. Mozuriene, V. Krungleviciute, A. Novoslavskij, A. Santini, I. Rozentale, G. Juodeikiene, and D. Cizeikiene. 2017. The impact of lactic acid bacteria with antimicrobial properties on biodegradation of polycyclic aromatic hydrocarbons and biogenic amines in cold smoked pork sausages. Food Control. 71:285–92. doi: 10.1016/j.foodcont.2016.07.010.
  • Bazuro, G., F. Torino, G. Gasparini, and L. Capurso. 2008. Chemoprevention in gastrointestinal adenocarcinoma: For few but not for all? Minerva Gastroenterologica e Dietologica 54 (4):429–44.
  • Bergounioux, J., R. Elisee, A.-L. Prunier, F. Donnadieu, B. Sperandio, P. Sansonetti, and L. Arbibe. 2012. Calpain activation by the Shigella flexneri effector VirA regulates key steps in the formation and life of the bacterium’s epithelial niche. Cell Host & Microbe 11 (3):240–52. doi: 10.1016/j.chom.2012.01.013.
  • Bermudez-Brito, M., J. Plaza-Díaz, S. Munoz-Quezada, C. Gomez-Llorente, and A. Gil. 2012. Probiotic mechanisms of action. Annals of Nutrition & Metabolism 61 (2):160–74. doi: 10.1159/000342079.
  • Chen, D., D. Jin, S. Huang, J. Wu, M. Xu, T. Liu, W. Dong, X. Liu, S. Wang, W. Zhong, et al. 2020. Clostridium butyricum, a butyrate-producing probiotic, inhibits intestinal tumor development through modulating Wnt signaling and gut microbiota. Cancer Letters 469:456–67. doi: 10.1016/j.canlet.2019.11.019.
  • Chen, M., P. Xu, G. Zeng, C. Yang, D. Huang, and J. Zhang. 2015. Bioremediation of soils contaminated with polycyclic aromatic hydrocarbons, petroleum, pesticides, chlorophenols and heavy metals by composting: Applications, microbes and future research needs. Biotechnology Advances 33 (6 Pt 1):745–55. doi: 10.1016/j.biotechadv.2015.05.003.
  • Choi, H. J., M. S. Shin, S. M. Lee, and W. K. Lee. 2012. Immunomodulatory properties of Enterococcus faecium JWS 833 isolated from duck intestinal tract and suppression of Listeria monocytogenes infection. Microbiology and Immunology 56 (9):613–20. doi: 10.1111/j.1348-0421.2012.00486.x.
  • Christophersen, C. T., A. Petersen, T. R. Licht, and M. A. Conlon. 2013. Xylo-oligosaccharides and inulin affect genotoxicity and bacterial populations differently in a human colonic simulator challenged with soy protein. Nutrients 5 (9):3740–56. doi: 10.3390/nu5093740.
  • Chuah, L.-O., H. L. Foo, T. C. Loh, N. B. M. Alitheen, S. K. Yeap, N. E. A. Mutalib, R. A. Rahim, and K. Yusoff. 2019. Postbiotic metabolites produced by Lactobacillus plantarum strains exert selective cytotoxicity effects on cancer cells. BMC Complementary and Alternative Medicine 19 (1):114. doi: 10.1186/s12906-019-2528-2.
  • Cicenia, A., A. Scirocco, M. Carabotti, L. Pallotta, M. Marignani, and C. Severi. 2014. Postbiotic activities of lactobacilli-derived factors. Journal of Clinical Gastroenterology 48:S18–S22.
  • Cohen, P. A. 2018. Probiotic safety—no guarantees. JAMA Internal Medicine 178 (12):1577–8. doi: 10.1001/jamainternmed.2018.5403.
  • de Almada, C. N., C. N. Almada, R. C. Martinez, and A. S. Sant’Ana. 2016. Paraprobiotics: Evidences on their ability to modify biological responses, inactivation methods and perspectives on their application in foods. Trends in Food Science & Technology 58:96–114.
  • de Almeida, C. V., A. Taddei, and A. Amedei. 2018. The controversial role of Enterococcus faecalis in colorectal cancer. Therapeutic Advances in Gastroenterology 11:175628481878360. doi: 10.1177/1756284818783606.
  • de Melo Pereira, G. V., B. de Oliveira Coelho, A. I. M. Júnior, V. Thomaz-Soccol, and C. R. Soccol. 2018. How to select a probiotic? A review and update of methods and criteria. Biotechnology Advances 36 (8):2060–76. doi: 10.1016/j.biotechadv.2018.09.003.
  • Doron, S., and D. R. Snydman. 2015. Risk and safety of probiotics. Clinical Infectious Diseases 60 (suppl_2):S129–S134. doi: 10.1093/cid/civ085.
  • dos Reis, S. A., L. L. da Conceição, N. P. Siqueira, D. D. Rosa, L. L. da Silva, and G. P. Maria do Carmo. 2017. Review of the mechanisms of probiotic actions in the prevention of colorectal cancer. Nutrition Research 37:1–19. doi: 10.1016/j.nutres.2016.11.009.
  • Dunand, E., P. Burns, A. Binetti, C. Bergamini, G. Peralta, L. Forzani, J. Reinheimer, and G. Vinderola. 2019. Postbiotics produced at laboratory and industrial level as potential functional food ingredients with the capacity to protect mice against Salmonella infection. Journal of Applied Microbiology 127 (1):219–29. doi: 10.1111/jam.14276.
  • Ejtahed, H. S., J. Mohtadi-Nia, A. Homayouni-Rad, M. Niafar, M. Asghari-Jafarabadi, and V. Mofid. 2012. Probiotic yogurt improves antioxidant status in type 2 diabetic patients. Nutrition 28 (5):539–43. doi: 10.1016/j.nut.2011.08.013.
  • El-Nezami, H., P. Kankaanpää, S. Salminen, and J. Ahokas. 1998. Physicochemical alterations enhance the ability of dairy strains of lactic acid bacteria to remove aflatoxin from contaminated media. Journal of Food Protection 61 (4):466–8. doi: 10.4315/0362-028X-61.4.466.
  • Eslami, M., B. Yousefi, P. Kokhaei, M. Hemati, Z. R. Nejad, V. Arabkari, and A. Namdar. 2019. Importance of probiotics in the prevention and treatment of colorectal cancer. Journal of Cellular Physiology 234 (10):17127–43. doi: 10.1002/jcp.28473.
  • Ewaschuk, J. B., J. W. Walker, H. Diaz, and K. L. Madsen. 2006. Bioproduction of conjugated linoleic acid by probiotic bacteria occurs in vitro and in vivo in mice. The Journal of Nutrition 136 (6):1483–7. doi: 10.1093/jn/136.6.1483.
  • Fijan, S. 2014. Microorganisms with claimed probiotic properties: An overview of recent literature. International Journal of Environmental Research and Public Health 11 (5):4745–67. doi: 10.3390/ijerph110504745.
  • Francescone, R., V. Hou, and S. I. Grivennikov. 2014. Microbiome, inflammation and cancer. Cancer Journal (Sudbury, MA), 20 (3):181.
  • Fritschi, L., G. Benke, H. A. Risch, A. Schulte, P. M. Webb, D. C. Whiteman, J. Fawcett, and R. E. Neale. 2015. Occupational exposure to N-nitrosamines and pesticides and risk of pancreatic cancer. Occupational and Environmental Medicine 72 (9):678–83. doi: 10.1136/oemed-2014-102522.
  • Fujiki, T., Y. Hirose, Y. Yamamoto, and S. Murosaki. 2012. Enhanced immunomodulatory activity and stability in simulated digestive juices of Lactobacillus plantarum L-137 by heat treatment. Bioscience, Biotechnology, and Biochemistry 76 (5):918–22. doi: 10.1271/bbb.110919.
  • Galimberti, A., A. Bruno, V. Mezzasalma, F. De Mattia, I. Bruni, and M. Labra. 2015. Emerging DNA-based technologies to characterize food ecosystems. Food Research International 69:424–33. doi: 10.1016/j.foodres.2015.01.017.
  • Gao, J., Y. Li, Y. Wan, T. Hu, L. Liu, S. Yang, Z. Gong, Q. Zeng, Y. Wei, W. Yang, et al. 2019. A novel postbiotic from Lactobacillus rhamnosus GG with a beneficial effect on intestinal barrier function. Frontiers in Microbiology 10:477. doi: 10.3389/fmicb.2019.00477.
  • Generoso, S. V., M. L. Viana, R. G. Santos, R. M. Arantes, F. S. Martins, J. R. Nicoli, J. A. Machado, M. I. T. Correia, and V. N. Cardoso. 2011. Protection against increased intestinal permeability and bacterial translocation induced by intestinal obstruction in mice treated with viable and heat-killed Saccharomyces boulardii. European Journal of Nutrition 50 (4):261–9. doi: 10.1007/s00394-010-0134-7.
  • Gezginc, Y., I. Akyol, E. Kuley, and F. Özogul. 2013. Biogenic amines formation in Streptococcus thermophilus isolated from home-made natural yogurt. Food Chemistry 138 (1):655–62. doi: 10.1016/j.foodchem.2012.10.138.
  • Goldenberg, J. Z., C. Yap, L. Lytvyn, C. K. F. Lo, J. Beardsley, D. Mertz, and B. C. Johnston. 2017. Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children. Cochrane Database of Systematic Reviews 12:CD006095. doi: 10.1002/14651858.CD006095.pub4.
  • Guéniche, A., P. Bastien, J. M. Ovigne, M. Kermici, G. Courchay, V. Chevalier, L. Breton, and I. Castiel‐-Higounenc. 2010. Bifidobacterium longum lysate, a new ingredient for reactive skin. Experimental Dermatology 19 (8):e1–e8. doi: 10.1111/j.1600-0625.2009.00932.x.
  • Han, K. J., N.-K. Lee, H. Park, and H.-D. Paik. 2015. Anticancer and anti-inflammatory activity of probiotic Lactococcus lactis NK34. Journal of Microbiology and Biotechnology 25 (10):1697–701. doi: 10.4014/jmb.1503.03033.
  • Hatakka, K., M. Mutanen, R. Holma, M. Saxelin, and R. Korpela. 2008. Lactobacillus rhamnosus LC705 together with Propionibacterium freudenreichii ssp shermanii JS administered in capsules is ineffective in lowering serum lipids. Journal of the American College of Nutrition 27 (4):441–7. doi: 10.1080/07315724.2008.10719723.
  • Homayouni Rad, A., L. Aghebati Maleki, H. Samadi Kafil, and A. Abbasi. 2020. Postbiotics: A novel strategy in food allergy treatment. Critical Reviews in Food Science and Nutrition 12:1–8. doi: 10.1080/10408398.2020.1738333. [Epub ahead of print]
  • Imperial, I. C., and J. A. Ibana. 2016. Addressing the antibiotic resistance problem with probiotics: Reducing the risk of its double-edged sword effect. Frontiers in Microbiology 7:1983. doi: 10.3389/fmicb.2016.01983.
  • Ishikawa, H., E. Kutsukake, T. Fukui, I. Sato, T. Shirai, T. Kurihara, N. Okada, H. Danbara, M. Toba, N. Kohda, et al. 2010. Oral administration of heat-killed Lactobacillus plantarum strain b240 protected mice against Salmonella enterica Serovar Typhimurium. Bioscience, Biotechnology, and Biochemistry 74 (7):1338–42. doi: 10.1271/bbb.90871.
  • Jafari, B., R. A. K. Nejad, F. Vaziri, and S. D. Siadat. 2019. Evaluation of the effects of extracellular vesicles derived from Faecalibacterium prausnitzii on lung cancer cell line. Biologia 74 (7):889–98. doi: 10.2478/s11756-019-00229-8.
  • Joint, F. 2002. WHO working group report on drafting guidelines for the evaluation of probiotics in food. London, Ontario, Canada, 30.
  • Kahouli, I., C. Tomaro-Duchesneau, and S. Prakash. 2013. Probiotics in colorectal cancer (CRC) with emphasis on mechanisms of action and current perspectives. Journal of Medical Microbiology 62 (Pt 8):1107–23. doi: 10.1099/jmm.0.048975-0.
  • Kamrani, A., A. Mehdizadeh, M. Ahmadi, L. Aghebati-Maleki, and M. Yousefi. 2019. Therapeutic approaches for targeting receptor tyrosine kinase like orphan receptor-1 in cancer cells. Expert Opinion on Therapeutic Targets 23 (5):447–56. doi: 10.1080/14728222.2019.1602608.
  • Kim, M. J., S. Ku, S. Y. Kim, H. H. Lee, H. Jin, S. Kang, R. Li, T. V. Johnston, M. S. Park, and G. E. Ji. 2018. Safety Evaluations of Bifidobacterium bifidum BGN4 and Bifidobacterium longum BORI. International Journal of Molecular Sciences 19 (5):1422. doi: 10.3390/ijms19051422.
  • Kim, Y., D. Lee, D. Kim, J. Cho, J. Yang, M. Chung, K. Kim, and N. Ha. 2008. Inhibition of proliferation in colon cancer cell lines and harmful enzyme activity of colon bacteria by Bifidobacterium adolescentis SPM0212. Archives of Pharmacal Research 31 (4):468–73. doi: 10.1007/s12272-001-1180-y.
  • Konishi, H., M. Fujiya, H. Tanaka, N. Ueno, K. Moriichi, J. Sasajima, K. Ikuta, H. Akutsu, H. Tanabe, and Y. Kohgo. 2016. Probiotic-derived ferrichrome inhibits colon cancer progression via JNK-mediated apoptosis. Nature Communications 7 (1):1–12. doi: 10.1038/ncomms12365.
  • Kostic, A. D., E. Chun, L. Robertson, J. N. Glickman, C. A. Gallini, M. Michaud, T. E. Clancy, D. C. Chung, P. Lochhead, G. L. Hold, et al. 2013. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host & Microbe 14 (2):207–15. doi: 10.1016/j.chom.2013.07.007.
  • Krebs, B. 2016. Prebiotic and Synbiotic treatment before colorectal surgery-randomised double blind trial. Collegium Antropologicum 40 (1):35–40.
  • Kumar, K. S., N. Sastry, H. Polaki, and V. Mishra. 2015. Colon cancer prevention through probiotics: An overview. Journal of Cancer Science and Clinical Therapeutics 7 (2):081–92.
  • Kumar, M., R. Nagpal, V. Verma, A. Kumar, N. Kaur, R. Hemalatha, S. K. Gautam, and B. Singh. 2013. Probiotic metabolites as epigenetic targets in the prevention of colon cancer. Nutrition Reviews 71 (1):23–34. doi: 10.1111/j.1753-4887.2012.00542.x.
  • Kurata, N., N. Tokashiki, K. Fukushima, T. Misao, N. Hasuoka, K. Kitagawa, M. Mashimo, J. W. Regan, T. Murayama, and H. Fujino. 2019. Short chain fatty acid butyrate uptake reduces expressions of prostanoid EP4 receptors and their mediation of cyclooxygenase-2 induction in HCA-7 human colon cancer cells. European Journal of Pharmacology 853:308–15. doi: 10.1016/j.ejphar.2019.04.014.
  • Lahtinen, S. J. 2012. Probiotic viability–does it matter? Microbial Ecology in Health and Disease 23 (1):18567.
  • Lara-Tejero, M., and J. E. Galán. 2000. A bacterial toxin that controls cell cycle progression as a deoxyribonuclease I-like protein. Science (New York, N.Y.) 290 (5490):354–7. doi: 10.1126/science.290.5490.354.
  • Lee, J.-E., J. Lee, J. H. Kim, N. Cho, S. H. Lee, S. B. Park, B. Koh, D. Kang, S. Kim, and H. M. Yoo. 2019. Characterization of the anti-cancer activity of the probiotic bacterium Lactobacillus fermentum using 2D vs. 3D culture in colorectal cancer cells. Biomolecules 9 (10):557. doi: 10.3390/biom9100557.
  • Lee, N.-K., S.-H. Son, E. B. Jeon, G. H. Jung, J.-Y. Lee, and H.-D. Paik. 2015. The prophylactic effect of probiotic Bacillus polyfermenticus KU3 against cancer cells. Journal of Functional Foods 14:513–8. doi: 10.1016/j.jff.2015.02.019.
  • Lim, H. Y., H. J. Joo, J. H. Choi, J. W. Yi, M. S. Yang, D. Y. Cho, H. S. Kim, D. K. Nam, K. B. Lee, and H. C. Kim. 2000. Increased expression of cyclooxygenase-2 protein in human gastric carcinoma. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 6 (2):519–25.
  • Lin, W. H., B. Yu, C. K. Lin, W. Z. Hwang, and H. Y. Tsen. 2007. Immune effect of heat‐killed multistrain of Lactobacillus acidophilus against Salmonella typhimurium invasion to mice. Journal of Applied Microbiology 102 (1):22–31. doi: 10.1111/j.1365-2672.2006.03073.x.
  • Ma, E. L., Y. J. Choi, J. Choi, C. Pothoulakis, S. H. Rhee, and E. Im. 2010. The anticancer effect of probiotic Bacillus polyfermenticus on human colon cancer cells is mediated through ErbB2 and ErbB3 inhibition. International Journal of Cancer 127 (4):780–90. doi: 10.1002/ijc.25011.
  • Maggiora, M.,. M. Bologna, M. P. Cerù, L. Possati, A. Angelucci, A. Cimini, A. Miglietta, F. Bozzo, C. Margiotta, G. Muzio, et al. 2004. An overview of the effect of linoleic and conjugated‐linoleic acids on the growth of several human tumor cell lines. International Journal of Cancer 112 (6):909–19. doi: 10.1002/ijc.20519.
  • Malagón-Rojas, J. N., A. Mantziari, S. Salminen, and H. Szajewska. 2020. Postbiotics for preventing and treating common infectious diseases in children: A systematic review. Nutrients 12 (2):389. doi: 10.3390/nu12020389.
  • Matthew Omoruyi, I., M. Hokkanen, and R. Pohjanvirta. 2019. Polycyclic Aromatic Hydrocarbons (PAHs) in select commercially processed meat and fish products in finland and the mutagenic potential of these food items. Polycyclic Aromatic Compounds 11:1–7. doi: 10.1080/10406638.2018.1509360.
  • Mego, M.,. J. Chovanec, I. Vochyanova-Andrezalova, P. Konkolovsky, M. Mikulova, M. Reckova, V. Miskovska, B. Bystricky, J. Beniak, L. Medvecova, et al. 2015. Prevention of irinotecan induced diarrhea by probiotics: A randomized double blind, placebo controlled pilot study. Complementary Therapies in Medicine 23 (3):356–62. doi: 10.1016/j.ctim.2015.03.008.
  • Mendonça, L. A., R. dos Santos Ferreira, R. de Cássia Avellaneda Guimarães, A. P. de Castro, O. L. Franco, R. Matias, and C. M. Carvalho. 2018. The complex puzzle of interactions among functional food, gut microbiota, and colorectal cancer. Frontiers in Oncology 8:325. doi: 10.3389/fonc.2018.00325.
  • Miyazawa, K., F. He, M. Kawase, A. Kubota, K. Yoda, and M. Hiramatsu. 2011. Enhancement of immunoregulatory effects of Lactobacillus gasseri TMC0356 by heat treatment and culture medium. Letters in Applied Microbiology 53 (2):210–6. doi: 10.1111/j.1472-765X.2011.03093.x.
  • Moludi, J., M. Alizadeh, N. L. Yagin, Y. Pasdar, S. M. Nachvak, H. Abdollahzad, and A. S. Tabaei. 2018. New insights on atherosclerosis: A cross-talk between endocannabinoid systems with gut microbiota. Journal of Cardiovascular and Thoracic Research 10 (3):129–37. doi: 10.15171/jcvtr.2018.21.
  • Moss, S. F. 2017. The clinical evidence linking Helicobacter pylori to gastric cancer. Cellular and Molecular Gastroenterology and Hepatology 3 (2):183–91. doi: 10.1016/j.jcmgh.2016.12.001.
  • Naghmouchi, K., Y. Belguesmia, F. Bendali, G. Spano, B. S. Seal, and D. Drider. 2019. Lactobacillus fermentum: A bacterial species with potential for food preservation and biomedical applications. Critical Reviews in Food Science and Nutrition 15:1–13. doi: 10.1080/10408398.2019.1688250. [Epub ahead of print]
  • Nakamura, S., T. Kuda, C. An, T. Kanno, H. Takahashi, and B. Kimura. 2012. Inhibitory effects of Leuconostoc mesenteroides 1RM3 isolated from narezushi, a fermented fish with rice, on Listeria monocytogenes infection to Caco-2 cells and A/J mice. Anaerobe 18 (1):19–24. doi: 10.1016/j.anaerobe.2011.11.006.
  • Netzker, T., J. Fischer, J. Weber, D. J. Mattern, C. C. König, V. Valiante, V. Schroeckh, and A. A. Brakhage. 2015. Microbial communication leading to the activation of silent fungal secondary metabolite gene clusters. Frontiers in Microbiology 6:299. doi: 10.3389/fmicb.2015.00299.
  • Nouri, Z., F. Karami, N. Neyazi, M. H. Modarressi, R. Karimi, M. R. Khorramizadeh, B. Taheri, and E. Motevaseli. 2016. Dual anti-metastatic and anti-proliferative activity assessment of two probiotics on HeLa and HT-29 cell lines. Cell Journal (Yakhteh) 18 (2):127.
  • Nozari, S., Y. Faridvand, A. Etesami, M. Ahmad Khan Beiki, S. A. Miresmaeili Mazrakhondi, and J. Abdolalizadeh. 2019. Potential anticancer effects of cell wall protein fractions from Lactobacillus paracasei on human intestinal Caco‐2 cell line. Letters in Applied Microbiology 69 (3):148–54. doi: 10.1111/lam.13198.
  • Ordóñez, J. L., A. M. Troncoso, M. D. C. García-Parrilla, and R. M. Callejón. 2016. Recent trends in the determination of biogenic amines in fermented beverages–A review. Analytica Chimica Acta 939:10–25. doi: 10.1016/j.aca.2016.07.045.
  • Orlando, A., M. Refolo, C. Messa, L. Amati, P. Lavermicocca, V. Guerra, and F. Russo. 2012. Antiproliferative and proapoptotic effects of viable or heat-killed Lactobacillus paracasei IMPC2.1 and Lactobacillus rhamnosus GG in HGC-27 gastric and DLD-1 colon cell lines. Nutrition and Cancer 64 (7):1103–11. doi: 10.1080/01635581.2012.717676.
  • Österlund, P., T. Ruotsalainen, R. Korpela, M. Saxelin, A. Ollus, P. Valta, M. Kouri, I. Elomaa, and H. Joensuu. 2007. Lactobacillus supplementation for diarrhoea related to chemotherapy of colorectal cancer: A randomised study. British Journal of Cancer 97 (8):1028–34. doi: 10.1038/sj.bjc.6603990.
  • Ou, C. C., S. L. Lin, J. J. Tsai, and M. Y. Lin. 2011. Heat‐killed lactic acid bacteria enhance immunomodulatory potential by skewing the immune response toward Th1 polarization. Journal of Food Science 76 (5):M260–M267. doi: 10.1111/j.1750-3841.2011.02161.x.
  • Papadimitriou, K., G. Zoumpopoulou, B. Foligné, V. Alexandraki, M. Kazou, B. Pot, and E. Tsakalidou. 2015. Discovering probiotic microorganisms: In vitro, in vivo, genetic and omics approaches. Frontiers in Microbiology 6:58. doi: 10.3389/fmicb.2015.00058.
  • Peng, L., Z.-R. Li, R. S. Green, I. R. Holzman, and J. Lin. 2009. Butyrate enhances the intestinal barrier by facilitating tight junction assembly via activation of AMP-activated protein kinase in Caco-2 cell monolayers. The Journal of Nutrition 139 (9):1619–25. doi: 10.3945/jn.109.104638.
  • Perez, M., E. Astó, P. Huedo, C. Alcántara, D. Buj, and J. Espadaler. 2020. Derived postbiotics of a multi‐strain probiotic formula clinically validated for the treatment of irritable bowel syndrome. The FASEB Journal 34 (S1):1. doi: 10.1096/fasebj.2020.34.s1.05062.
  • Piqué, N., M. Berlanga, and D. Miñana-Galbis. 2019. Health benefits of heat-killed (Tyndallized) probiotics: An overview. International Journal of Molecular Sciences 20 (10):2534. doi: 10.3390/ijms20102534.
  • Rad, A. H., F. Akbarzadeh, and E. V. Mehrabany. 2012. Which are more important: Prebiotics or probiotics? Nutrition 28 (11-12):1196–1197. doi: 10.1016/j.nut.2012.03.017.
  • Rad, A. H., L. A. Maleki, H. S. Kafil, H. F. Zavoshti, and A. Abbasi. 2020. Postbiotics as novel health-promoting ingredients in functional foods. Health Promotion Perspectives 10 (1):3–4. doi: 10.15171/hpp.2020.02.
  • Raman, M., P. Ambalam, K. K. Kondepudi, S. Pithva, C. Kothari, A. T. Patel, R. K. Purama, J. Dave, and B. Vyas. 2013. Potential of probiotics, prebiotics and synbiotics for management of colorectal cancer. Gut Microbes 4 (3):181–192. doi: 10.4161/gmic.23919.
  • Rubin, H. 2001. Synergistic mechanisms in carcinogenesis by polycyclic aromatic hydrocarbons and by tobacco smoke: A bio-historical perspective with updates. Carcinogenesis 22 (12):1903–1930. doi: 10.1093/carcin/22.12.1903.
  • Rubinstein, M. R., X. Wang, W. Liu, Y. Hao, G. Cai, and Y. W. Han. 2013. Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/β-catenin signaling via its FadA adhesin. Cell Host & Microbe 14 (2):195–206. doi: 10.1016/j.chom.2013.07.012.
  • Russo, E., G. Bacci, C. Chiellini, C. Fagorzi, E. Niccolai, A. Taddei, F. Ricci, M. N. Ringressi, R. Borrelli, F. Melli, et al. 2018. Preliminary comparison of oral and intestinal human microbiota in patients with colorectal cancer: A pilot study. Frontiers in Microbiology 8:2699. doi: 10.3389/fmicb.2017.02699.
  • Sadeghi-Aliabadi, H., F. Mohammadi, H. Fazeli, and M. Mirlohi. 2014. Effects of Lactobacillus plantarum A7 with probiotic potential on colon cancer and normal cells proliferation in comparison with a commercial strain. Iranian Journal of Basic Medical Sciences 17 (10):815–819.
  • Sadreddini, S.,. Baradaran, B. Aghebati‐Maleki, A. Sadreddini, S. Shanehbandi, D. Fotouhi, A.. and Aghebati‐Maleki L. 2019. Immune checkpoint blockade opens a new way to cancer immunotherapy. Journal of Cellular Physiology 234 (6):8541–8549. doi: 10.1002/jcp.27816.
  • Sadreddini, S.,. R. Safaralizadeh, B. Baradaran, L. Aghebati-Maleki, M. A. Hosseinpour-Feizi, D. Shanehbandi, F. Jadidi-Niaragh, S. Sadreddini, H. S. Kafil, V. Younesi, et al. 2017. Chitosan nanoparticles as a dual drug/siRNA delivery system for treatment of colorectal cancer. Immunology Letters 181:79–86. doi: 10.1016/j.imlet.2016.11.013.
  • Sanders, M. E., L. M. A. Akkermans, D. Haller, C. Hammerman, J. Heimbach, G. Hörmannsperger, G. Huys, D. D. Levy, F. Lutgendorff, D. Mack, et al. 2010. Safety assessment of probiotics for human use. Gut Microbes 1 (3):164–185. doi: 10.4161/gmic.1.3.12127.
  • Sanders, M. E., F. Guarner, R. Guerrant, P. R. Holt, E. M. Quigley, R. B. Sartor, P. M. Sherman, and E. A. Mayer. 2013. An update on the use and investigation of probiotics in health and disease. Gut 62 (5):787–796. doi: 10.1136/gutjnl-2012-302504.
  • Saxami, G., A. Karapetsas, E. Lamprianidou, I. Kotsianidis, A. Chlichlia, C. Tassou, V. Zoumpourlis, and A. Galanis. 2016. Two potential probiotic lactobacillus strains isolated from olive microbiota exhibit adhesion and anti-proliferative effects in cancer cell lines. Journal of Functional Foods 24:461–471. doi: 10.1016/j.jff.2016.04.036.
  • Sentürk, M., F. Ercan, and S. Yalcin. 2020. The secondary metabolites produced by Lactobacillus plantarum downregulate BCL-2 and BUFFY genes on breast cancer cell line and model organism Drosophila melanogaster: Molecular docking approach. Cancer Chemotherapy and Pharmacology 85 (1):33–45. doi: 10.1007/s00280-019-03978-0.
  • Sharma, M., D. Chandel, and G. Shukla. 2020. Antigenotoxicity and cytotoxic potentials of metabiotics extracted from isolated probiotic, Lactobacillus rhamnosus MD 14 on Caco-2 and HT-29 human colon cancer cells. Nutrition and Cancer 72 (1):110–10. doi: 10.1080/01635581.2019.1615514.
  • Shenderov, B. A. 2013. Metabiotics: Novel idea or natural development of probiotic conception. Microbial Ecology in Health and Disease 24 (1):20399.
  • Shigwedha, N., L. Sichel, L. Jia, and L. Zhang. 2014. Probiotical cell fragments (PCFs) as “novel nutraceutical ingredients. Journal of Biosciences and Medicines 02 (03):43–55. doi: 10.4236/jbm.2014.23007.
  • Siegel, R. L., K. D. Miller, and A. Jemal. 2019. Cancer statistics, 2019. CA: A Cancer Journal for Clinicians 69 (1):7–34. doi: 10.3322/caac.21551.
  • Singh, B., and S. Mitragotri. 2019. Harnessing cells to deliver nanoparticle drugs to treat cancer. Biotechnology Advances 11:pii:S0734–9750(19)30006-0. doi: 10.1016/j.biotechadv.2019.01.006. [Epub ahead of print]
  • Smith, R. A., K. S. Andrews, D. Brooks, S. A. Fedewa, D. Manassaram‐Baptiste, D. Saslow, and R. C. Wender. 2019. Cancer screening in the United States, 2019: A review of current American Cancer Society guidelines and current issues in cancer screening. CA: A Cancer Journal for Clinicians 69 (3):184–210. doi: 10.3322/caac.21557.
  • Sokol, H., B. Pigneur, L. Watterlot, O. Lakhdari, L. G. Bermudez-Humaran, J.-J. Gratadoux, S. Blugeon, C. Bridonneau, J.-P. Furet, G. Corthier, et al. 2008. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proceedings of the National Academy of Sciences 105 (43):16731–16736. doi: 10.1073/pnas.0804812105.
  • Song, H., W. Wang, B. Shen, H. Jia, Z. Hou, P. Chen, and Y. Sun. 2018. Pretreatment with probiotic Bifico ameliorates colitis‐associated cancer in mice: Transcriptome and gut flora profiling. Cancer Science 109 (3):666–677. doi: 10.1111/cas.13497.
  • Tan, H. K., H. L. Foo, T. C. Loh, N. B. M. Alitheen, and R. A. Rahim. 2015. Cytotoxic effect of proteinaceous postbiotic metabolites produced by Lactobacillus plantarum I-UL4 cultivated in different media composition on MCF-7 breast cancer cell. Malaysian Journal of Microbiology 11 (2):207–214.
  • Taylor, A. L., J. A. Dunstan, and S. L. Prescott. 2007. Probiotic supplementation for the first 6 months of life fails to reduce the risk of atopic dermatitis and increases the risk of allergen sensitization in high-risk children: A randomized controlled trial. The Journal of Allergy and Clinical Immunology 119 (1):184–191. doi: 10.1016/j.jaci.2006.08.036.
  • Thirabunyanon, M., P. Boonprasom, and P. Niamsup. 2009. Probiotic potential of lactic acid bacteria isolated from fermented dairy milks on antiproliferation of colon cancer cells. Biotechnology Letters 31 (4):571–576. doi: 10.1007/s10529-008-9902-3.
  • Thirabunyanon, M., and P. Hongwittayakorn. 2013. Potential probiotic lactic acid bacteria of human origin induce antiproliferation of colon cancer cells via synergic actions in adhesion to cancer cells and short-chain fatty acid bioproduction. Applied Biochemistry and Biotechnology 169 (2):511–525. doi: 10.1007/s12010-012-9995-y.
  • Tiptiri-Kourpeti, A., K. Spyridopoulou, V. Santarmaki, G. Aindelis, E. Tompoulidou, E. E. Lamprianidou, G. Saxami, P. Ypsilantis, E. S. Lampri, C. Simopoulos, et al. 2016. Lactobacillus casei exerts anti-proliferative effects accompanied by apoptotic cell death and up-regulation of TRAIL in colon carcinoma cells. Plos One 11 (2):e0147960. doi: 10.1371/journal.pone.0147960.
  • Tiptiri-Kourpeti, A., K. Spyridopoulou, V. Santarmaki, G. Aindelis, E. Tompoulidou, E. E. Lamprianidou, G. Saxami, P. Ypsilantis, E. S. Lampri, C. Simopoulos, et al. 2016. Lactobacillus casei exerts anti-proliferative effects accompanied by apoptotic cell death and up-regulation of TRAIL in colon carcinoma cells. PloS One 11 (2):e0147960-e0147960. doi: 10.1371/journal.pone.0147960.
  • Tjalsma, H., A. Boleij, J. R. Marchesi, and B. E. Dutilh. 2012. A bacterial driver–passenger model for colorectal cancer: Beyond the usual suspects. Nature Reviews. Microbiology 10 (8):575–582. doi: 10.1038/nrmicro2819.
  • Tomasik, P., and P. Tomasik. 2020. Probiotics, non-dairy prebiotics and postbiotics in nutrition. Applied Sciences 10 (4):1470. doi: 10.3390/app10041470.
  • Tsilingiri, K., T. Barbosa, G. Penna, F. Caprioli, A. Sonzogni, G. Viale, and M. Rescigno. 2012. Probiotic and postbiotic activity in health and disease: Comparison on a novel polarised ex-vivo organ culture model. Gut 61 (7):1007–1015. doi: 10.1136/gutjnl-2011-300971.
  • Tsilingiri, K., and M. Rescigno. 2013. Postbiotics: What else? Beneficial Microbes 4 (1):101–107. doi: 10.3920/BM2012.0046.
  • Tsuda, H., K. Hara, and T. Miyamoto. 2008. Binding of mutagens to exopolysaccharide produced by Lactobacillus plantarum mutant strain 301102S. Journal of Dairy Science 91 (8):2960–2966. doi: 10.3168/jds.2007-0538.
  • Tukenmez, U., B. Aktas, B. Aslim, and S. Yavuz. 2019. The relationship between the structural characteristics of lactobacilli-EPS and its ability to induce apoptosis in colon cancer cells in vitro. Scientific Reports 9 (1):8268. doi: 10.1038/s41598-019-44753-8.
  • Tuohy, K., G. Rouzaud, W. Bruck, and G. Gibson. 2005. Modulation of the human gut microflora towards improved health using prebiotics-assessment of efficacy. Current Pharmaceutical Design 11 (1):75–90. doi: 10.2174/1381612053382331.
  • Vaghef-Mehrabany, E., L. Vaghef-Mehrabany, M. Asghari-Jafarabadi, A. Homayouni-Rad, K. Issazadeh, and B. Alipour. 2017. Effects of probiotic supplementation on lipid profile of women with rheumatoid arthritis: A randomized placebo-controlled clinical trial. Health Promotion Perspectives 7 (2):95–101. doi: 10.15171/hpp.2017.17.
  • Van Hoffen, E., N. M. Korthagen, S. De Kivit, B. Schouten, B. Bardoel, A. Duivelshof, J. Knol, J. Garssen, and L. E. Willemsen. 2010. Exposure of intestinal epithelial cells to UV-killed Lactobacillus GG but not Bifidobacterium breve enhances the effector immune response in vitro. International Archives of Allergy and Immunology 152 (2):159–168. doi: 10.1159/000265537.
  • Venegas, D. P., K. Marjorie, G. Landskron, M. J. Gonz_alez, R. Quera, G. Dijkstra, H. J. Harmsen, K. N. Faber, and M. A. Hermoso. 2019. Short chain fatty acids (SCFAs)-mediated gut epithelial and immune regulation and its relevance for inflammatory bowel diseases. Frontiers in Immunology 10:277. doi: 10.3389/fimmu.2019.00277.
  • Vernazza, C. L., B. A. Rabiu, and G. R. Gibson. 2006. Human colonic microbiology and the role of dietary intervention: Introduction to prebiotics. Prebiotics: Development and Application 2006:1–28.
  • Vidal, K., A. Donnet-Hughes, and D. Granato. 2002. Lipoteichoic acids from Lactobacillus johnsonii strain La1 and Lactobacillus acidophilus strain La10 antagonize the responsiveness of human intestinal epithelial HT29 cells to lipopolysaccharide and gram-negative bacteria. Infection and Immunity 70 (4):2057–2064. doi: 10.1128/IAI.70.4.2057-2064.2002.
  • Wang, J., W. Hui, C. Cao, R. Jin, C. Ren, H. Zhang, and W. Zhang. 2016. Proteomic analysis of an engineered isolate of Lactobacillus plantarum with enhanced raffinose metabolic capacity. Scientific Reports 6 (1):31403. doi: 10.1038/srep31403.
  • Wang, L., H. Cao, L. Liu, B. Wang, W. A. Walker, S. A. Acra, and F. Yan. 2014. Activation of epidermal growth factor receptor mediates mucin production stimulated by p40, a Lactobacillus rhamnosus GG-derived protein. The Journal of Biological Chemistry 289 (29):20234–20244. doi: 10.1074/jbc.M114.553800.
  • Wang, Y., Y. Liu, I. Kirpich, Z. Ma, C. Wang, M. Zhang, J. Suttles, C. McClain, and W. Feng. 2013. Lactobacillus rhamnosus GG reduces hepatic TNFα production and inflammation in chronic alcohol-induced liver injury. The Journal of Nutritional Biochemistry 24 (9):1609–1615. doi: 10.1016/j.jnutbio.2013.02.001.
  • Wirbel, J., P. T. Pyl, E. Kartal, K. Zych, A. Kashani, A. Milanese, J. S. Fleck, A. Y. Voigt, A. Palleja, R. Ponnudurai, et al. 2019. Meta-analysis of fecal metagenomes reveals global microbial signatures that are specific for colorectal cancer. Nature Medicine 25 (4):679–689. doi: 10.1038/s41591-019-0406-6.
  • Xu, Y., J. Zang, J. M. Regenstein, and W. Xia. 2020. Technological roles of microorganisms in fish fermentation: A review. Critical Reviews in Food Science and Nutrition 15:1–13. doi: 10.1080/10408398.2020.1750342. [Epub ahead of print]
  • Yang, Y., C. Xu, D. Wu, Z. Wang, P. Wu, L. Li, J. Huang, and F. Qiu. 2018. γδ T Cells: Crosstalk between microbiota, chronic inflammation, and colorectal cancer. Frontiers in Immunology 9:1483. doi: 10.3389/fimmu.2018.01483.
  • Yao, Y., and W. Dai. 2014. Genomic instability and cancer. Journal of Carcinogenesis & Mutagenesis 5:1000165. doi: 10.4172/2157-2518.1000165.
  • Yoda, K., K. Miyazawa, M. Hosoda, M. Hiramatsu, F. Yan, and F. He. 2014. Lactobacillus GG-fermented milk prevents DSS-induced colitis and regulates intestinal epithelial homeostasis through activation of epidermal growth factor receptor. European Journal of Nutrition 53 (1):105–115. doi: 10.1007/s00394-013-0506-x.
  • Yousefi, B., M. Eslami, A. Ghasemian, P. Kokhaei, A. Salek Farrokhi, and N. Darabi. 2019. Probiotics importance and their immunomodulatory properties. Journal of Cellular Physiology 234 (6):8008–8018. doi: 10.1002/jcp.27559.
  • Zeng, J., J. Jiang, W. Zhu, and Y. Chu. 2016. Heat-killed yogurt-containing lactic acid bacteria prevent cytokine-induced barrier disruption in human intestinal Caco-2 cells. Annals of Microbiology 66 (1):171–178. doi: 10.1007/s13213-015-1093-2.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.